Notice of Intent to Grant Exclusive Patent License to Centimani, LLC; San Diego, CA

Name of License: 
Notice of Intent to Grant Exclusive Patent License to Centimani, LLC; San Diego, CA
By the: 
Army Research Laboratory (ARL)
Summary 

DEPARTMENT OF DEFENSE

Department of the Army

Notice of Intent to Grant Exclusive Patent License to Centimani, LLC; San Diego, CA

AGENCY: Department of the Army, DoD.

ACTION: Notice of Intent.
SUMMARY: The Department of the Army hereby gives notice of its intent to grant to Centimani, LLC; a company having its principle place of business at 3766 Wawona Dr. San Diego, CA 92107, an exclusive license.

Tech Name: 
Third Arm Weapon Interface System
Action: 
Intent
Dates: 
Written objections must be filed not later than 15 days following publication of this announcement.
Address: 
ADDRESSES: Send written objections to U.S. Army Combat Capabilities Development Command Army Research Laboratory, Strategic Partnerships Office, FCDD-RLD-FS /Annmarie Martin, Building 321 Room 126, 6375 Johnson Rd., Aberdeen Proving Ground, MD 21005-5425 or e-mail to ORTA@arl.army.mil.
For further information contact 

FOR FURTHER INFORMATION CONTACT: Annmarie Martin, (410) 278-9106, E-Mail: ORTA@arl.army.mil

Supplementary information 

SUPPLEMENTARY INFORMATION: The Department of the Army plans to grant an exclusive license to Centimani, LLC in all fields of use pertaining to the following;
- ‘‘Third Arm Weapon Interface System”, ARL 17-28, US Patent No. 10,393,476, Issue Date: 08/27/2019. US Patent Application No. 16/002,420, Filing Date: 06/07/2018.

The prospective exclusive license may be granted unless within fifteen (15) days from the date of this published notice, the U.S. Army Combat Capabilities Development Command Army Research Laboratory receives written objections including evidence and argument that establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). Competing applications completed and received by the U.S. Army Combat Capabilities Development Command Army Research Laboratory within fifteen (15) days from the date of this published notice will also be treated as objections to the grant of the contemplated exclusive license.
Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552.

Correction: